F2 and oculocerebrorenal syndrome: Because PT dysfunction is the first manifestation of kidney disease observed in young infants with Dent disease 2 and Lowe syndrome, an early treatment of such PT dysfunction, leading to improvements in the metabolic profile and growth, might therefore slow progression to chronic kidney disease and therefore have a significant impact on lifespan and quality of life.33